Ultrasonic Tissue Ablation System Market Size is poised to grow considerably over 2022-2028 with the ongoing transformation of the healthcare sector through the adoption of advanced medical instruments. The growing awareness among people about the early disease diagnosis and treatment procedures for various chronic diseases will support the industry expansion by 2028.
The increasing burden of neurological disease, gynecological disease, cardiac disorders, etc. has instigated the demand for ultrasonic tissue ablation. It is known to be the most advanced bioeffect of focused ultrasound which generates cell death in a specific area without causing any significant damage to the surrounding tissue. The demand for these solutions, backed by the increasing initiatives to enhance healthcare infrastructure, is anticipated to open new opportunities for the ultrasonic tissue ablation system market in the following years.
With regards to the product type, high-intensity focused ultrasound (HIFU) segment is projected to grow notably over the analysis timeframe of 2022-2028. The growth can be attributed to the increasing application of HIFU in the treatment of both primary as well as metastatic tumors owing to its ability to locate ablation precisely. It is known to be a suitable treatment for liver tumors. The rising cases of liver cancer are expected to further drive the segmental growth in the coming years. According to the American Cancer Society’s statistics, every year, over 800,000 people are diagnosed with liver cancer around the world.
In terms of application, cancer segment is expected to record substantial gains by the end of 2028 with the increasing awareness among people about cancer diagnosis and treatment across developed as well as developing nations. The rising cases of cancer across the globe is largely impelling the demand for ultrasonic tissue ablation systems. As per the National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP), every year, over 1.6 million people in the U.S. are diagnosed with cancer and is known to be the second-largest cause of death in the country. Another important factor supporting the market growth is the rising R&D investments in cancer treatment by the key business players.
Regionally, North America is estimated to emerge as a growth avenue for ultrasonic tissue ablation system market over the forecast period. This can be ascribed to the increasing investments in the healthcare infrastructure across the region. In addition, the rising cases of chronic disorders, requiring various advanced treatment solution is further contributing to the market growth.
The prominent companies active in ultrasonic tissue ablation system market are Misonix, Integra LifeSciences, Ethicon (Johnson & Johnson), Alpinion Medical Systems (ILJIN Holdings Co., Ltd), Insightec, Chongqing Haifu Medical Technology, Shanghai A&S Science Technology Development, Mianyang Sonic Electronic, and Theraclion.
These market players are inclined towards the development of innovative solutions to effectively cater to consumer demand and increase their competitiveness in the industry. To illustrate, in 2020, Integra LifeSciences received FDA approval for a neurosurgery indication for its Clarity Ultrasonic Surgical Aspirator System- CUSA. According to the company, it is the first ever ultrasonic tissue ablation system to have received approval to treat malignant and benign tumors.
The outbreak of COVID-19 has made a serious impact on ultrasonic tissue ablation system market outlook as the surgical practices were affected due to the lockdown restrictions and growing concerns among patients about the risk of coronavirus infection. Various surgical procedures were temporary halted in order to meet the increasing healthcare demand during the pandemic. However, as the healthcare settings are practicing the safety norms pertaining to coronavirus and are going back to carrying out surgical procedures, the market is anticipated to grow significantly over the foreseeable future.
Market, by Type
Market, by Application
Market, by End-use
The above information is provided for the following regions and countries: